" class="no-js "lang="en-US"> Peter Marks - Medtech Alert
Monday, June 17, 2024

Peter Marks

About Peter Marks

Peter Marks, M.D., Ph.D. is the director of the Center for Biologics Evaluation and Research (CBER) at the Food and Drug Administration. The center is responsible for assuring the safety and effectiveness of biological products, including vaccines, allergenic products, blood and blood products, and cellular, tissue, and gene therapies.

Related Story

FDA Approves Innovative Treatment for Pediatric Patients with Congenital Athymia

October 11 2021

Today, the U.S. Food and Drug Administration approved Rethymic for the treatment of pediatric patients […]

FDA approves new treatment for adults with relapsed or refractory large-b-cell lymphoma

February 10 2021

Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy […]